Categories: News

Acquisition of Common Shares of Tres-Or Resources Ltd.

KELOWNA, British Columbia, Jan. 08, 2021 (GLOBE NEWSWIRE) — Kiboko Exploration Inc. (“Kiboko” or the “Company“) is announcing that it has filed an early warning report for securities of Tres-Or Resources Ltd. of 1934-131 Street, White Rock, B.C., V4A 7R7 (“Tres-Or“) (TSXV: TRS, OTCPK: TRSFF) in accordance with Multilateral Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issuers.

On December 31, 2020, Kiboko acquired 1,333,334 common shares and 666,667 common share purchase warrants of Tres-Or through the purchase of 1,333,334 units at a price of $0.15 per unit for a total of $200,000.10. Kiboko had understood that Tres-Or would issue a minimum of 1,666,666 flow through units (rather than 1,246,433) and 1,666,666 common share units (rather than 1,470,001) through its private placement, which would had resulted in Kiboko maintaining a less than 10% interest in Tres-Or, on a non-diluted or partially diluted basis.

Immediately prior to the issuance of the units, Kiboko held no shares of Tres-Or, either directly or indirectly. Immediately following the issuance of the units and as of today’s date, Kiboko holds, directly or indirectly, 1,333,334 common shares (representing approximately 7.2% of the issued and outstanding common shares of Tres-Or) and 666,667 common share purchase warrants, which are convertible into 666,667 common shares (which, assuming exercise of all warrants, represents approximately 10.4% of Tres-Or’s issued and outstanding common shares).

Kiboko’s participation in the private placement satisfied one of the funding requirements under the terms of the Fontana gold project option agreement entered into on June 6, 2019 between Kiboko and Tres-Or. The securities noted above are held for investment and working capital purposes.

In addition, on December 23, 2020, Kiboko sold 1,026,316 warrants of Tres-Or and over a series of sales made through the facilities of the TSX Venture Exchange on January 31, 2020, Kiboko sold 400,000 common shares of the Corporation.

In accordance with applicable securities laws, Kiboko may, from time to time and at any time, acquire additional common shares and/or other equity, debt, or other securities or instruments (collectively, “Securities“) of Tres-Or in the open market or otherwise, and reserves the right to dispose of any or all of its Securities in the open market or otherwise at any time and from time to time, and to engage in similar transactions with respect to the Securities, the whole depending on market conditions, the business and prospects of Tres-Or and other relevant factors.

Tres-Or’s Head Office is located at 1934 – 131 Street, White Rock, British Columbia, Canada V4A 7R7.

The early warning report with respect to the foregoing will appear on Tres-Or’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. A copy may also be obtained by calling Kiboko at +1 (778) 381-5949 or emailing Kiboko at moreinfo@kibokoexploration.com.

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

6 minutes ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

6 minutes ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

6 minutes ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

6 minutes ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

6 minutes ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

36 minutes ago